From: MALDI-TOF-MS analysis in discovery and identification of serum proteomic patterns of ovarian cancer
 | SNN | QC | GA |
---|---|---|---|
Recognition capability (%) | 80.30 | 72.73 | 93.94 |
Cross validation (%) | 63.64 | 68.18 | 54.55 |
Sensitivity (%) | 71.00 | 77.40 | 87.10 |
Specificity (%) | 68.60 | 51.40 | 48.60 |